Elisabetta Teodori

Via U. Schiff 6
Sesto Fiorentino, 50019, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 60 publications

Targeting Protein Tyrosine Phosphatase 1B: Recent Advances in Natural, Synthetic, and Multitarget Inhibitors for Diabetes Therapy.

Targeting Protein Tyrosine Phosphatase 1B: Recent Advances in Natural, Synthetic, and Multitarget Inhibitors for Diabetes Therapy.

Journal: Biomolecules

Published: June 23, 2026

Correction: Kopecka et al. Insights into P-Glycoprotein Inhibitors: New Inducers of Immunogenic Cell Death. Cells 2020, 9, 1033.

Correction: Kopecka et al. Insights into P-Glycoprotein Inhibitors: New Inducers of Immunogenic Cell Death. Cells 2020, 9, 1033.

Journal: Cells

Published: April 21, 2026

Piperazine Derivatives Carrying an Imidazole Ring as Selective Modulators of Human Carbonic Anhydrase Isozymes.

Piperazine Derivatives Carrying an Imidazole Ring as Selective Modulators of Human Carbonic Anhydrase Isozymes.

Journal: ChemMedChem

Published: February 24, 2026

New benzyldiazepane derivatives able to reduce biofilm formation in Escherichia coli.

New benzyldiazepane derivatives able to reduce biofilm formation in Escherichia coli.

Journal: Bioorganic & medicinal chemistry letters

Published: February 05, 2026

Dual Inhibitors of P-gp and Carbonic Anhydrase XII (hCA XII) against Tumor Multidrug Resistance with Piperazine Scaffold.

Dual Inhibitors of P-gp and Carbonic Anhydrase XII (hCA XII) against Tumor Multidrug Resistance with Piperazine Scaffold.

Journal: Molecules (Basel, Switzerland)

Published: May 29, 2024

Mass Spectrometry Study about In Vitro and In Vivo Reaction between Metformin and Glucose: A Preliminary Investigation on Alternative Biological Behavior.

Mass Spectrometry Study about In Vitro and In Vivo Reaction between Metformin and Glucose: A Preliminary Investigation on Alternative Biological Behavior.

Journal: International journal of molecular sciences

Published: November 24, 2023

Synthetic Approaches to Piperazine-Containing Drugs Approved by FDA in the Period of 2011-2023.

Synthetic Approaches to Piperazine-Containing Drugs Approved by FDA in the Period of 2011-2023.

Journal: Molecules (Basel, Switzerland)

Published: November 24, 2023

Tetrazole and oxadiazole derivatives as bioisosteres of tariquidar and elacridar: New potent P-gp modulators acting as MDR reversers.

Tetrazole and oxadiazole derivatives as bioisosteres of tariquidar and elacridar: New potent P-gp modulators acting as MDR reversers.

Journal: European journal of medicinal chemistry

Published: May 11, 2023

Isomers Recognition in HPLC-MS/MS Analysis of Human Plasma Samples by Using an Ion Trap Supported by a Linear Equations-Based Algorithm.

Isomers Recognition in HPLC-MS/MS Analysis of Human Plasma Samples by Using an Ion Trap Supported by a Linear Equations-Based Algorithm.

Journal: International journal of molecular sciences

Published: April 26, 2023

The human proton pump inhibitors inhibit Mycobacterium tuberculosis rifampicin efflux and macrophage-induced rifampicin tolerance.

The human proton pump inhibitors inhibit Mycobacterium tuberculosis rifampicin efflux and macrophage-induced rifampicin tolerance.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: February 10, 2023

Recent Advances in the Discovery of Nicotinic Acetylcholine Receptor Allosteric Modulators.

Recent Advances in the Discovery of Nicotinic Acetylcholine Receptor Allosteric Modulators.

Journal: Molecules (Basel, Switzerland)

Published: December 21, 2022

New Dual P-Glycoprotein (P-gp) and Human Carbonic Anhydrase XII (hCA XII) Inhibitors as Multidrug Resistance (MDR) Reversers in Cancer Cells.

New Dual P-Glycoprotein (P-gp) and Human Carbonic Anhydrase XII (hCA XII) Inhibitors as Multidrug Resistance (MDR) Reversers in Cancer Cells.

Journal: Journal of medicinal chemistry

Published: October 21, 2022

Showing 1-12 of 60

Last Updated: 09/26/2026